AVENTIS PHARMA LIMITED
Get an alert when AVENTIS PHARMA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£136k
+3.8% vs 2024
Net assets
£1.5bn
+2% vs 2024
Employees
596
+1.9% vs 2024
Profit before tax
£54m
-29.2% lowest in 3 filed years
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £384,877,000 | £414,634,000 | £418,768,000 | +1% | |
| Operating profit | £17,893,000 | -£7,498,000 | £1,121,000 | +115% | |
| Profit before tax | £71,861,000 | £76,557,000 | £54,173,000 | -29.2% | |
| Net profit | £54,915,000 | £72,906,000 | — | — | |
| Cash | £144,000 | £131,000 | £136,000 | +3.8% | |
| Total assets less current liabilities | £1,476,971,000 | £1,530,589,000 | £1,484,747,000 | -3% | |
| Net assets | £1,524,758,000 | £1,433,232,000 | £1,461,305,000 | +2% | |
| Equity | £1,524,758,000 | £1,433,232,000 | £1,461,305,000 | +2% | |
| Average employees | 666 | 585 | 596 | +1.9% | |
| Wages | £70,110,000 | £70,966,000 | £66,048,000 | -6.9% | |
| Directors' remuneration | £480,000 | £1,338,000 | £579,000 | -56.7% | |
| Directors' pension contributions | £46,000 | £59,000 | £43,000 | -27.1% | |
| Highest paid director | £312,000 | £679,000 | £355,000 | -47.7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 4.6% | -1.8% | 0.3% | |
| Net margin | 14.3% | 17.6% | — | |
| Return on capital employed | 1.2% | -0.5% | 0.1% | |
| Gearing (liabilities / total assets) | 20.5% | 22.9% | 16.5% | |
| Current ratio | 3.47x | 5.24x | 6.07x | |
| Interest cover | 4.64x | -2.31x | 1.74x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 4 times since incorporation
- AVENTIS PHARMA LIMITED 1999-12-16 → present
- MARION MERRELL LIMITED 1995-09-14 → 1999-12-16
- MARION MERRELL DOW LIMITED 1992-01-06 → 1995-09-14
- MERRELL DOW PHARMACEUTICALS LIMITED 1983-12-06 → 1992-01-06
- MERRELL PHARMACEUTICALS LIMITED 1980-12-18 → 1983-12-06
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The company is expected to continue to generate profits and positive cash flows for the foreseeable future.”
Group structure
- AVENTIS PHARMA LIMITED · parent
- Genzyme Therapeutics Limited 100%
- May & Baker Limited 100%
- Fisons Limited 100%
- Rhone-Poulenc Rorer Limited 100%
Significant events
- “On 7 April 2026 the company, by way of special resolution reduced its share premium to £Nil. Subsequently transferring the share premium to the profit and loss reserves account.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 38 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MOHAMED, Walaa Mostafa Abbas Awad | Director | 2026-02-01 | Oct 1977 | Egyptian |
| MOUSSA, Ahmed Mohamed Moustafa | Director | 2026-02-01 | Aug 1984 | Egyptian |
Show 38 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AROZENA, Fernando | Secretary | 1992-07-06 | 1995-09-19 |
| CLAPHAM, Christopher Edward | Secretary | 1995-09-19 | 2001-06-30 |
| MCCLELLAN, Michael James | Secretary | 2008-02-13 | 2010-05-12 |
| NICHOLLS, David John | Secretary | 2001-06-30 | 2004-02-23 |
| ROBERTS, Helen | Secretary | 2004-12-20 | 2008-01-30 |
| SMITH, Suzanne Elaine | Secretary | 2004-02-23 | 2004-12-20 |
| WALES, William Wesley | Secretary | — | 1992-07-06 |
| ASHTON, David Thomas | Director | 1997-12-16 | 2000-02-18 |
| BAIRD, Jessamy Rachel | Director | 2021-08-19 | 2024-03-01 |
| BRISSON, Gilles Denis | Director | 2004-11-08 | 2006-06-01 |
| BROOKSBY, Nigel Stanley | Director | 2004-11-08 | 2010-05-12 |
| BROWN, Elliot Graham, Dr | Director | 1993-04-16 | 1995-07-28 |
| CANNON, Paul Douglas Victor | Director | 1993-04-16 | 1995-09-20 |
| CHANCEL, Pierre | Director | 2004-05-19 | 2004-11-08 |
| DE FORCEVILLE, Guillaume Adrien | Director | 2004-11-08 | 2007-11-16 |
| DUHALDE, Francois-Xavier | Director | 2016-04-01 | 2021-03-31 |
| FRY, Hugo Rupert Alexander | Director | 2017-01-01 | 2021-03-31 |
| GARIJO, Belen | Director | 2006-07-01 | 2011-07-01 |
| GUENTER, Peter Antoan | Director | 2012-02-28 | 2015-01-26 |
| IRWIN, Thomas Ronald | Director | — | 1993-04-16 |
| KHAN, Usman | Director | 2021-03-31 | 2026-02-01 |
| LADELL, Peter William | Director | — | 2000-01-06 |
| LOESCHER, Peter | Director | 1997-11-10 | 1999-09-01 |
| LOEW, David Mathias | Director | 2015-02-13 | 2016-04-01 |
| MASHETER, Harold Crossley | Director | — | 1993-04-16 |
| MCCLELLAN, Michael James | Director | 2007-11-16 | 2010-10-01 |
| MITCHUM, James Paul | Director | 1999-09-01 | 2002-12-13 |
| NICHOLLS, David John | Director | 1999-12-16 | 2004-11-08 |
| OLDFIELD, Stephen Philip | Director | 2010-05-12 | 2014-07-25 |
| PROSSER, Andrew Michael James | Director | 2010-09-01 | 2016-04-01 |
| QUINOT, Jean Michel | Director | 1997-10-27 | 1997-11-14 |
| REES, David Hugh Thomas | Director | 2000-02-18 | 2004-11-08 |
| SCHIKORR, Wolfgang, Dr | Director | 1995-09-20 | 1997-11-10 |
| STENVALL, Tarja Johanna | Director | 2014-11-19 | 2016-09-30 |
| SZAPARY, Laszlo | Director | 2000-02-28 | 2004-11-08 |
| TILLETT, Gordon Michael | Director | 2021-03-31 | 2021-08-19 |
| UBHI, Rippondeep | Director | 2024-03-01 | 2026-02-01 |
| VIOLINI, Guiseppe | Director | — | 1993-04-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Sanofi-Aventis Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 239 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-04-14 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-25 | AA | accounts | Accounts with accounts type full | |
| 2026-04-14 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2026-04-14 | SH20 | capital | Legacy | |
| 2026-04-14 | CAP-SS | insolvency | Legacy | |
| 2026-04-14 | RESOLUTIONS | resolution | Resolution | |
| 2026-02-05 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-05 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-05 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-05 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-05 | AA | accounts | Accounts with accounts type full | |
| 2025-05-27 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2025-05-19 | CH01 | officers | Change person director company with change date | |
| 2025-02-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-15 | AA | accounts | Accounts with accounts type full | |
| 2024-03-03 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-25 | AA | accounts | Accounts with accounts type full | |
| 2023-01-06 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 11
- Capital events
- 2
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.